Variant position: 501 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 563 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human FGGILSLINEHRILSGRPPL GFLNPRLYQ---------QHG-----------------AGLFDVTRG--
Chimpanzee FGGILSLINEHRILSGRPPL GFLNPRLYQ---------QHG
Mouse FGGILSLINEHRILNGRPPL GFLNPRLYQ---------QHG
Rat FGGILSLINEHRLLNGRPPL GFLNPRLYQ---------QHG
Bovine FGGLLSLINEHRILRGLPPL GFLNPRLYQ---------KHG
Slime mold IAGLLSLINDQRLQKNQSPI GLFNPLLYKIAR------DHP
Baker's yeast FAENLHVEF----------- ------------------KYP
Fission yeast LEELVCSKYDVEIMRGKANL EVRPSSINKGGIVKQILSSYP
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses.
Kousi M.; Lehesjoki A.E.; Mole S.E.;
Hum. Mutat. 33:42-63(2012)
Cited for: VARIANTS CLN2 THR-62; HIS-209; GLN-266; GLN-339; ARG-382; VAL-448; CYS-501; TYR-504 AND ARG-548;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.